The Venture Codex Logo

The Venture Codex

Overview

Supports medical device companies to improve health outcomes.

Founded

2023

Deals ยท 12mo

5

Stage focus

Series B
Series C
Series D

Geographic focus

Ireland
United Kingdom
United States

Sector focus

Finance
Financial Services

Investment portfolio

11rounds
NAMEDATESIZE
Elucid
Sep 2026Participated
$55 MSeries D
Nervonik
Apr 2026Participated
$53 MSeries B
Imperative Care
Mar 2026Led
$100 MOther Equity
Nuclera
Jan 2026Led
$12 MSeries C
Biobeat
Dec 2025Led
$50 MSeries B
Galvanize Therapeutics
Sep 2025Participated
$100 MSeries C
SetPoint Medical
Aug 2025Led
$140 MSeries D
FIRE1
Jan 2025Led
$120 MOther Equity
Nuclera
Oct 2024Led
$77 MSeries C
Moximed
Aug 2024Led
$61 MSeries D
Elucid
Nov 2023Led
$80 MSeries C
Elucid
Sep 2026Participated
$55 MSeries D
Nervonik
Apr 2026Participated
$53 MSeries B
Imperative Care
Mar 2026Led
$100 MOther Equity
Nuclera
Jan 2026Led
$12 MSeries C
Biobeat
Dec 2025Led
$50 MSeries B
Galvanize Therapeutics
Sep 2025Participated
$100 MSeries C
SetPoint Medical
Aug 2025Led
$140 MSeries D
FIRE1
Jan 2025Led
$120 MOther Equity
Nuclera
Oct 2024Led
$77 MSeries C
Moximed
Aug 2024Led
$61 MSeries D
Elucid
Nov 2023Led
$80 MSeries C
11
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Elevage Medical Technologies: 11 funding rounds are recorded in the selected participation categories.All available history.
Elevage Medical Technologies: 11 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series B11
Series C+52
Other Equity20

Monthly Deal Activity

Elevage Medical Technologies: 11 deals are recorded across 36 months.All available history.
Elevage Medical Technologies: 11 deals are recorded across 36 months. All available history
MonthDeals
Nov '231
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '241
Sep '240
Oct '241
Nov '240
Dec '240
Jan '251
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '251
Sep '251
Oct '250
Nov '250
Dec '251
Jan '261
Feb '260
Mar '261
Apr '261
May '260
Jun '260
Jul '260
Aug '260
Sep '261
Oct '260

Sector Breakdown

Elevage Medical Technologies: Health & Life Sciences is the largest displayed sector by deal count (11 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Elevage Medical Technologies: Health & Life Sciences is the largest displayed sector by deal count (11 deals). All available history
SectorDeals
Health & Life Sciences11
Data, Analytics & IT3
Hardware & Robotics1
Manufacturing1

Deal Size Distribution

Elevage Medical Technologies: 11 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Elevage Medical Technologies: 11 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M1
$25M-$50M0
$50M-$100M6
$100M-$250M4
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Elevage Medical Technologies: United States has the largest recorded deal count among the displayed regions (8 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Elevage Medical Technologies: United States has the largest recorded deal count among the displayed regions (8 deals). All available history
RegionDeals
United States8
Europe3
Elevage Medical Technologies: 20 co-investors are shown, with Ally Bridge Group sharing 4 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Investment Strategy

Elevage Medical Technologies: Led accounts for 73% and participating for 27% of round participation.All available history.
Elevage Medical Technologies: Led accounts for 73% and participating for 27% of round participation. All available history
CategoryDeals (count)Share (%)
Led873%
Participating327%
Elevage Medical Technologies: Single-lead accounts for 50% and co-led for 50% of lead dynamics.All available history.
Elevage Medical Technologies: Single-lead accounts for 50% and co-led for 50% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead450%
Co-led450%

Team

Evan Melrose

Managing Director

Michael Wasserman

Bord of Directors